Abstract

In this study, we have investigated the effect of panaxatriol (PT) on phosphoinositides (PIS) breakdown and <TEX>$Ca^{2+}$</TEX>-elevation in thrombin-induced platelet aggregation. Thrombin (5U/ml), a potent platelet agonist which activates phospholipase <TEX>$C_{\beta}$</TEX> via protease activated receptor (PAR), hydrolyzed PIS in platelet membrane. The phosphatidylinositol 4, 5-bisphosphate <TEX>$(PIP_2)$</TEX> was hydrolyzed after 10 sec of the thrombin-stimulation, and both the phosphatidylinositol 4-monophosphate (PIP) and phosphatidylinositol (PI) were brokendown after 30 sec of the thrombin-stimulation. However, PT inhibited the thrombin-stimulated hydrolysis of <TEX>$PIP_2$</TEX>, PIP, and PI. On the other hand, thrombin increased the level of phosphatidic acid (PA) which is phosphorylated from diacylglycerol (DG) generated by PIS-hydrolysis. However, Pr inhibited the thrombin-increased PA level non-significantly. Thrombin increased cytosolic free <TEX>$Ca^{2+}([Ca^{2+}])_i$</TEX>) up to 72% as compared with control <TEX>$(30.8{\pm}0.9 nM)$</TEX> in intact platelet. However, PT (100 <TEX>${\mu}g/ml$</TEX>) inhibited the thrombin-elevated <TEX>$[Ca^{2+}]_i$</TEX> to 100%. These results suggest that PT may have a beneficial effect on platelet aggregation-mediated thrombotic disease by inhibiting thrombin-induced platelet aggregation via suppression of the <TEX>$[Ca^{2+}]_i$</TEX> level and PIS breakdown.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call